ADMA Biologics Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices jump after Trump threatens to hit Iran 'very hard'
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
March 13, 2015 9:22 AM EDTAdma Biologics (NASDAQ: ADMA) announced the pricing of its previously announced underwritten public offering of 1,225,000 shares of common stock at a public offering price of $8.00 per share, resulting in gross proceeds of approximately $9,800,000.
The offering is expected to close on March 18, 2015, subject to the... More
